NICCAV, funded by the Canadian Global Health Research Initiative (GHRI) was implemented from October 2010 through December 2014 to build capacity for HIV vaccine research in Nigeria. The study whose Principal Investigator was, Dr. Alash’le Abimiku, built local capacity to implement vaccine trial in Nigerian by addressing three core objectives.
NICCAV, funded by the Canadian Global Health Research Initiative (GHRI) was implemented from October 2010 through December 2014 to build capacity for HIV vaccine research in Nigeria. The study whose Principal Investigator was, Dr. Alash’le Abimiku, built local capacity to implement vaccine trial in Nigerian by addressing three core objectives.
- Developing Capacity for HIV Vaccine Research and Oversight
- Vaccine Cohort Development & Community Engagement
- Building Laboratory Capacity to Support HIV Vaccine Trials
NICCAV study has provided a platform for future collaboration/partnerships with funders for a future HIV prevention trial in Nigeria.